# buRst-supprESsion TO Stop Refractory Status Epilepticus Post-cardiac Arrest

> **NCT05851391** · PHASE2 · RECRUITING · sponsor: **University of California, San Francisco** · enrollment: 30 (estimated)

## Conditions studied

- Hypoxia-Ischemia, Brain
- Heart Arrest
- Status Epilepticus
- Refractory Status Epilepticus
- Seizures
- Anoxic-Ischemic Encephalopathy
- Anoxia-Ischemia, Cerebral

## Interventions

- **DRUG:** Burst Suppression EEG Target Intravenous Anesthesia
- **DRUG:** Seizure Suppression EEG Target Intravenous Anesthesia

## Key facts

- **NCT ID:** NCT05851391
- **Lead sponsor:** University of California, San Francisco
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-08-07
- **Primary completion:** 2026-11-30
- **Final completion:** 2027-04-30
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2025-05-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05851391

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05851391, "buRst-supprESsion TO Stop Refractory Status Epilepticus Post-cardiac Arrest". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05851391. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*